Low or Intermediate Risk Prostate Cancer
2 clinical trials · Condition
◉ Watch Low or Intermediate Risk Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Phase I Study MR-guided SBRT to PCa (NCT03935308) | Henry Ford Health System | 2019-04-23 |
| Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin) (NCT00890006) | University Health Network, Toronto | 2006-09-01 |
Track Low or Intermediate Risk Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.